Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis.
Capra M, Martin T, Moreau P, Baker R, Pour L, Min CK, Leleu X, Mohty M, Segura MR, Turgut M, LeBlanc R, Risse ML, Malinge L, Schwab S, Dimopoulos M. Capra M, et al. Among authors: schwab s. Haematologica. 2022 Jun 1;107(6):1397-1409. doi: 10.3324/haematol.2021.279229. Haematologica. 2022. PMID: 34647444 Free PMC article. Clinical Trial.
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.
Facon T, Moreau P, Martin TG, Spicka I, Oriol A, Koh Y, Lim A, Mikala G, Rosiñol L, Yağci M, Cavo M, Yong K, Risse ML, Asset G, Schwab S, Martinez G. Facon T, et al. Among authors: schwab s. Hematol Oncol. 2022 Dec;40(5):1020-1029. doi: 10.1002/hon.3038. Epub 2022 Jun 8. Hematol Oncol. 2022. PMID: 35653225 Free PMC article.
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
Trnĕný M, Verhoef G, Dyer MJ, Ben Yehuda D, Patti C, Canales M, Lopez A, Awan FT, Montgomery PG, Janikova A, Barbui AM, Sulek K, Terol MJ, Radford J, Guidetti A, Di Nicola M, Siraudin L, Hatteville L, Schwab S, Oprea C, Gianni AM. Trnĕný M, et al. Among authors: schwab s. Haematologica. 2018 Aug;103(8):1351-1358. doi: 10.3324/haematol.2017.168401. Epub 2018 May 10. Haematologica. 2018. PMID: 29748443 Free PMC article. Clinical Trial.
Disparities in Diabetes Technology Uptake in Youth and Young Adults With Type 1 Diabetes: A Global Perspective.
Conway RB, Snell-Bergeon J, Honda-Kohmo K, Peddi AK, Isa SB, Sulong S, Sibomana L, Gerard Gonzalez A, Song J, Lomax KE, Lo CN, Kim W, Haynes A, de Bock M, Burckhardt MA, Schwab S, Hong K. Conway RB, et al. Among authors: schwab s. J Endocr Soc. 2024 Nov 28;9(1):bvae210. doi: 10.1210/jendso/bvae210. eCollection 2024 Nov 26. J Endocr Soc. 2024. PMID: 39703363 Free PMC article. Review.
Socioecological drivers of burnout - a mixed methods study of military health providers.
Olapeju B, Dong T, Soh M, Mushtaq O, Chang H, Riegleman D, Hemmer PA, Schwab SD, Shanahan P, Johnson-Boua K, Durning SJ. Olapeju B, et al. Among authors: schwab sd. Front Public Health. 2024 Nov 18;12:1410825. doi: 10.3389/fpubh.2024.1410825. eCollection 2024. Front Public Health. 2024. PMID: 39624411 Free PMC article.
[In-hospital management of intracerebral hemorrhage].
Sembill J, Schwab S. Sembill J, et al. Among authors: schwab s. Med Klin Intensivmed Notfmed. 2024 Nov 29. doi: 10.1007/s00063-024-01216-x. Online ahead of print. Med Klin Intensivmed Notfmed. 2024. PMID: 39611953 Review. German.
1,148 results